Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
| Title | FOA | Organization | Release Date | Expire Date | Purpose |
|---|---|---|---|---|---|
| Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) | RFA-CA-22-006 | NCI | The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U01 research projects. The… More | ||
| Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) | PAR-22-071 | NCI | This Funding Opportunity Announcement (FOA), entitled "Toward Translation of Nanotechnology Cancer Interventions" (TTNCI), encourages applications for advanced pre-clinical research,… More | ||
| National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) | PAR-20-077 | NCI | With this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for investigator-initiated Program Project (P01) applications. The proposed Program may… More | ||
| Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional) | PAR-19-352 | NCI | This Funding Opportunity Announcement (FOA) invites applications for intervention research designed to support caregivers of adult cancer patients. Interventions supported by this FOA are intended to… More | ||
| Biology of Bladder Cancer (R01 Clinical Trial Optional) | PAR-19-183 | NCI | This Funding Opportunity Announcement (FOA) solicits applications investigating the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem both in the… More | ||
| Notice of Intent to Publish a Funding Opportunity Announcement for Glioblastoma Therapeutics Network (U19 Clinical Trial Required) | NOT-CA-20-073 | NCI | N/A | Notice Intent Publish Funding Opportunity Announcement Glioblastoma Therapeutics Network U19 Clinical Trial Required) Notice Number: NOT-CA-20-073 Key Dates Release Date: June 23, 2020 Estimated… More | |
| Request for Proposals FNIH Cancer Steering Committee Project Concepts for Novel Biomarker Platforms to Support Novel Tissue Imaging, Remote Sensing, and Toxicity Challenges | NOT-CA-22-028 | NCI | N/A | The FNIH Biomarkers Consortium is issuing a Request for Proposals (RFP) for novel biomarker platforms to support the mission of the BC Cancer Steering Committee (CSC) High Content Data Integration… More | |
| Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed) | PAR-21-335 | NCI | The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the Research Units (RUs), one of the two scientific components of the Pancreatic Cancer Detection Consortium… More | ||
| NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) | PAR-21-302 | NCI | The purpose of the NCI Transition Career Development Award to Promote Diversity is to assist postdoctoral fellows or individuals in equivalent positions to transition to positions of assistant… More | ||
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) | RFA-CA-22-007 | NCI | The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U54 Resource-Related… More |